Table 1.
Characteristic | Distribution, % |
|
---|---|---|
1988–2000 | 2001–2014 | |
(n = 107 747) | (n = 117 746) | |
Cancer site | ||
Bone and soft tissue sarcoma | 2.4 | 2.7 |
Brain and CNS: Benign | — | 3.9 |
Brain and CNS: Invasive | 4.2 | 4.1 |
Breast | 14.1 | 13.8 |
Cervix | 6.2 | 4.5 |
Colorectal | 3.7 | 4.8 |
Kaposi sarcoma | 8.5 | 1.0 |
Kidney | 1.1 | 2.1 |
Leukemia: ALL | 1.3 | 1.8 |
Leukemia: AML | 1.7 | 1.9 |
Leukemia: CML | 0.9 | 0.9 |
Lip, oral cavity, and pharynx | 1.6 | 1.6 |
Lung | 1.8 | 1.3 |
Lymphoma: Hodgkin | 5.0 | 5.1 |
Lymphoma: Non-Hodgkin | 7.5 | 5.8 |
Melanoma | 10.6 | 9.1 |
Ovary: Carcinoma | 1.6 | 1.4 |
Ovary: Germ cell | 0.5 | 0.6 |
Stomach | 1.1 | 1.1 |
Testis | 7.5 | 8.5 |
Thyroid | 7.8 | 12.4 |
Uterus | 1.1 | 1.8 |
Other* | 9.8 | 9.7 |
Stage | ||
Localized | 46.5 | 51.6 |
Regional | 21.6 | 25.4 |
Distant | 21.1 | 18.8 |
In situ | 0.2 | 0.5 |
Unknown | 10.7 | 3.7 |
Sex | ||
Male | 46.9 | 40.7 |
Female | 53.1 | 59.3 |
Other or unknown | 0.0 | 0.0 |
Age group, y | ||
15–19 | 5.1 | 7.1 |
20–24 | 8.5 | 11.2 |
25–29 | 16.6 | 16.8 |
30–34 | 28.5 | 25.8 |
35–39 | 41.2 | 39.1 |
Race and ethnicity | ||
Asian and Pacific Islander | 7.3 | 9.8 |
Black | 6.9 | 5.7 |
Latino white | 23.1 | 33.5 |
Non-Latino white | 59.5 | 45.9 |
Other or unknown | 3.2 | 5.1 |
Socioeconomic status | ||
High | 21.3 | 20.3 |
Mid-high | 22.7 | 21.7 |
Middle | 20.9 | 20.4 |
Mid-low | 18.5 | 19.4 |
Low | 16.6 | 18.2 |
Other indicates all noncategorized invasive cancers and benign intracranial tumors. See Supplementary Table 2 (available online) for cancer sites included in other. Of the other cancers, 2% and 5.5% are in situ stage in 1988–2000 and 2001–2014, respectively. ALL = acute lymphocytic leukemia; AML = acute myeloid leukemia; CML = chronic myeloid leukemia; CNS = central nervous system.